Education
About Us
Working with TipRanks
Follow Us
Kirchgraber Paul R Insider Profile
4 Followers
Kirchgraber Paul R, CEO, Covance Drug Development at Laboratory, holds 7.70K shares in Laboratory (Ticker: LH). Most recently, Kirchgraber Paul R Sold $1,500 shares of Laboratory on Nov 06, 2020 for an estimated value of 321.19K.
Kirchgraber Paul R has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kirchgraber Paul R's holdings
Insider Roles
CEO, Covance Drug Development
Roles that Kirchgraber Paul R holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kirchgraber Paul R
Kirchgraber Paul R's Trading History
List of latest transactions for each holding click on a transaction to see Kirchgraber Paul R's performance on stock
You May Also Like
Kirchgraber Paul R insider profile FAQ
What is the percentage of profitable transactions made by Kirchgraber Paul R?
The percentage of profitable transactions made by Kirchgraber Paul R is ―.
What is the average return per transaction made by Kirchgraber Paul R?
The average return per transaction made by Kirchgraber Paul R is ―.
What stocks does Kirchgraber Paul R hold?
Kirchgraber Paul R holds: LH stocks.
What was Kirchgraber Paul R’s latest transaction?
Kirchgraber Paul R latest transaction was an Informative Sell of $321.19K.
What was Kirchgraber Paul R's most profitable transaction?
Kirchgraber Paul R’s most profitable transaction was an Informative Sell of LH stock on November 6, 2020. The return on the trade was 6.50%.
What is Kirchgraber Paul R's role in Laboratory?
Kirchgraber Paul R's role in Laboratory is CEO, Covance Drug Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.